Associated Papers
Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents.
Nitta S et al.
Scientific Reports, 2016
Naturally occurring HCV NS5A/B inhibitor resistance-associated mutations to direct-acting antivirals.
Nguyen LT et al.
Antiviral Therapy, 2016
Naturally occurring, resistance-associated hepatitis C virus NS5A variants are linked to interleukin-28B genotype and are sensitive to interferon-based therapy.
Itakura J et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 2015
Update on hepatitis C virus resistance to direct-acting antiviral agents.
Poveda E et al.
Antiviral Research, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirin.
Murakami E et al.
Antimicrobial Agents and Chemotherapy, 2014
Select a paper to view details